The prevention and management of treatment related morbidity in vulval cancer

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 17, Issue 4, 2003, Pages 683-701

  Barton, Desmond P J ^a,b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Morbidity; Prevention; Treatment; Vulval cancer

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ESTROGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LOPERAMIDE; NORMACOL; PENICILLIN G; PENTOXIFYLLINE; STEROID; SUCRALFATE;

ADJUVANT THERAPY; ADVANCED CANCER; ANTIBIOTIC PROPHYLAXIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONSERVATIVE TREATMENT; CYSTIC LYMPHANGIOMA; DRUG COST; DRUG EFFICACY; DYSPAREUNIA; EDEMA; EXERCISE; FEMALE; GYNECOLOGIC SURGERY; HUMAN; HYPERBARIC OXYGEN; INGUINAL HERNIA; LEG EDEMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; MENTAL DISEASE; MORBIDITY; MULTIMODALITY CANCER THERAPY; PARESTHESIA; PHYSICAL DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION INJURY; RECURRENT CANCER; REVIEW; SEXUAL DYSFUNCTION; SURGICAL INFECTION; THROMBOSIS; TREATMENT FAILURE; URETHRA DISEASE; VAGINA DISEASE; VULVA CANCER; VULVA DISEASE; VULVECTOMY; WOUND DRAINAGE;

EID: 0141718930     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6934(03)00045-2     Document Type: Review

References (71)

1. Office of National Statistics (ONS). Cancer Statistics Registrations. Series NBI, Number 30. 2002. (www.statistics.gov.uk).
2. Cancer facts and figures 2001. American Cancer Society (www.cancer.org).
3. Al-Ghamdi A, Freedman D, Miller D et al. Vulvar squamous cell carcinoma in young women: A clinicopathologic study of 21 cases. Gynecologic Oncology 2002; 84: 94-101.
4. Cavanagh D & Hoffman MS. Controversies in the management of vulvar carcinoma. British Journal of Obstetrics and Gynaecology 1996; 103: 293-300.
5. Andersen BL & Hacker NF. Psychosexual adjustment after vulvar surgery. Obstetrics and Gynecology 1983; 62: 457-462.
6. Cavanagh D & Shepherd JH. The place of pelvic exenteration in the primary management of advanced carcinoma of the vulva. Gynecologic Oncology 1982; 13: 318-322.
7. Pereira De Godoy JM, Braile DM, De Fatima Godoy M & Longo O. Jr. Quality of life and peripheral lymphedema. Lymphology 2002; 35: 72-75.
8. Hacker NF, Leuchter RS, Berek JS et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstetrics and Gynecology 1981; 58: 574-579.
9. Hopkins MP, Reid GC & Morley GW. Radical vulvectomy: The decision for the incision. Cancer 1993; 72: 799-803.
10. Maggino T, Landoni F, Sartori E et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. Cancer 2000; 89: 116-120.
11. Rouzier R, Haddad B, Plantier F et al. Local relapse in patients treated for squamous cell vulvar carcinoma: Incidence and prognostic value. Obstetrics and Gynecology 2002; 100: 1159-1167.
12. Heaps JM, Fu YS, Montz FJ et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecologic Oncology 1990; 38: 309-314.
13. De Hullu JA, Hollema H, Lolkema S et al. Vulvar carcinoma. The price of less radical surgery. Cancer 2002; 95: 2331-2338.
14. Flannelly GM, Foley ME, Lenehan PM et al. EN bloc radical vulvectomy and lymphadenectomy with modifications of separate groin incisions. Obstetrics and Gynecology 1992; 79: 307-309.
15. Baile WF, Kudelka AP, Beale EA et al. Communication skills training in oncology. Cancer 1999; 86: 887-897.
16. Baile WF, Lenzi R, Kudelka AP et al. Improving physician-patient communication in cancer care: Outcome of a workshop for oncologists. Journal of Cancer Education 1997; 12: 166-173.
17. Eindinger RN & Schapira DV. Cancer patients' insight into their treatment, prognosis and unconventional therapies. Cancer 1984; 53: 2736-2740.
18. Lind SE, DelVecchio Good MJ, Seidel S et al. Telling the diagnosis of cancer. Journal of Clinical Oncology 1989; 7: 583-589.
19. Lerman C, Daly M, Walsh WP et al. Communication between patients with breast cancer and healthcare provides. Determinants and implications. Cancer 1993; 72: 2612-2620.
20. Parker PA, Baile WF, De Moor C et al. Breaking bad news about cancer: Patients' preferences for communication. Journal of Clinical Oncology 2000; 19: 2049-2056.
21. Barnett MM. Effect of breaking bad news on patients' perceptions of doctors. Journal of the Royal Society of Medicine 2002; 95: 343-347.
22. Makar AP & Trope CG. Gynecologic malignancy and surgery: From quantity to quality of life. Current Opinion in Obstetrics and Gynecology 1999; 4: 419-429.
23. Corney RH, Crowther ME, Everett H et al. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. British Journal of Obstetrics and Gynaecology 1993; 100: 73-78.
24. Butler-Manuel SA, Sumerville K, Ford A et al. Self-assessment of morbidity following radical hysterectomy for cervical cancer. Journal of Obstetrics and Gynaecology 1999; 19: 180-183.
25. Pignata S, Ballatori E, Favalli G & Scambia G. Quality of life: Gynaecological cancers. Annals of Oncology 2001; 12(supplement 3): S37-S42.
26. Andreasson B, Moth I, Jensen SB & Bock JE. Sexual function and somapsychic reactions in vulvectomy-operated women and their partners. Acta Obstetrica and Gynaecologica Scandinavica 1986; 65: 7-10.
27. Thuesen B, Andreasson B & Bock JE. Sexual function and somapsychic reactions after local excision of vulvar intra-epithelial neoplasia. Acta Obstetrica and Gynaecologica Scandinavica 1992; 71: 126-128.
28. Green MS, Naumann RW, Elliot M et al. Sexual dysfunction following vulvectomy. Gynecologic Oncology 2000; 77: 73-77.
29. Wilson PD, Barker G, Barnard RJ & Siddle NC. Steroid hormone receptors in the lower female urinary tract. Urology International 1984; 39: 5-8.
30. Calame RJ. Pelvic relaxation as a complication of the radical vulvectomy. Obstetrics and Gynecology 1980; 55: 716-719.
31. Kadar N & Nelson JH Jr. Sling operation for total incontinence following radical vulvectomy. Obstetrics and Gynecology 1984; 64: 85-87.
32. Reid GC, DeLancey JOL, Hopkins MP et al. Urinary incontinence following radical vulvectomy. Obstetrics and Gynecology 1990; 75: 852-858.
33. Hoffman MS, LaPolla JP, Roberts WS et al. Use of local flaps for primary anal reconstruction following perianal resection for neoplasia. Gynecologic Oncology 1990; 36: 348-352.
34. Barton DPJ, Hoffman MS, Roberts WS et al. Use of local flaps in the preservation of fecal continence following resection of perianal neoplasias. International Journal of Gynecological Cancer 1993; 3: 318-323.
35. Berek JS, Lagasse LD, Hacker NF & Leuchter RS. Levator ani transposition for anal incompetence secondary to sphincter damage. Obstetrics and Gynecology 1982; 59: 108-112.
36. Roberts WS, Hoffman MS, La Polla JP et al. Management of radionecrosis of the vulva and distal vagina. American Journal of Obstetrics and Gynecology 1991; 164: 1235-1238.
37. Gould N, Kamelle S, Tillmans T et al. Predictors of complications after inguinal lymphadenectomy. Gynecologic Oncology 2001; 82: 329-332.
38. Hoffman MS, Mark JE & Cavanagh D. A management scheme for postoperative groin lymphocysts. Gynecologic Oncology 1995; 56: 262-265.
39. Van Lindert AC, Symons EA, Amen BF & Heintz AP. Wound healing after radical vulvectomy and inguinofemoral lymphadenectomy: Experience with granulocyte colony stimulating factor (filgrastim, r-metHuG-CSF). European Journal of Obstetrics and Gynecology and Reproductive Biology 1995; 62: 217-219.
40. Lavie O, Karmeli R, Mansano R et al. Treatment of recurrent inguinal lymphocele by lymphatic leakage mapping and subsequent ligation of lymphatic vessel endings: A case report. Gynecoogic Oncology 2002; 84: 155-156.
41. Maylor ME. Accurate selection of compression and antiembolic hosiery. British Journal of Nursing 2001; 10: 1172-1184.
42. Kouvaris JR, Kouloulias VE, Plataniotis GA & Balafouta EJL. Dermatitis during radiation for vulvar carcinoma: Prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze. Wound Repair and Regeneration 2001; 9: 187-193.
43. Denton AS & Maher EJ. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy (Cochrane Review). Oxford: The Cochrane Library, 2003. Issue I.
44. Berek JS, Hacker NF, Lagasse LD & Smith ML. Delayed vaginal reconstruction in the fibrotic pelvis following radiation or previous reconstruction. Obstetrics and Gynecology 1983; 61: 743-748.
45. Denton A, Forbes A, Andreyev J & Maher EJ. Non-surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis. (Cochrane Review). Oxford: The Cochrane Library, 2003. Issue I.
46. Denham JW, O'Brien PC, Dunstan RH et al. Is there more that one late radiation proctitis syndrome? Radiotherapy and Oncology 1999; 51: 43-53.
47. Wang CJ, Leung SW, Chen HC et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of a consequential late effect. International Journal of Radiation Oncology, Biology and Physics 1998; 40: 85-91.
48. Law WL, Choi HK, Chu KW & Tung HM. Radiation stricture of rectosigmoid treated with self-expanding metallic stent. Surgery and Endoscopy 2002; 16: 1106-1107.
49. Jeyarajah AR, Shepherd JH, Fairclough PD & Patchett SE. Effective palliation of a colovaginal fistula using a self-expanding metal stent. Gastrointestinal Endoscopy 1997; 46: 367-369.
50. Denton AS, Clarke NW & Maher EJ. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis (Cochrane Review). Oxford: The Cochrane Library, 2003. Issue I.
51. Elkins TE, DeLancey JO & McGuire EJ. The use of the Martius graft as an adjunctive technique in vesicovaginal and rectovaginal repair. Obstetrics and Gynecology 1990; 75: 727-733.
52. Leach GE. Urethrovaginal fistula repair with Martius labial fat pad graft. Urology Clinics of North America 1991; 18: 409-413.
53. Cooper R & Molan P. The use of honey as an antiseptic in managing Pseudomonas infection. Journal of Wound Care 1999; 8: 161-164.
54. Cooper RA, Molan PC & Harding KG. Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. Journal of the Royal Society of Medicine 1999; 92: 283-285.
55. Hyde SE, Ansink AC, Burger MP et al. The impact of performance status on survival in patients of 80 years and with vulvar cancer. Gynecologic Oncology 2002; 84: 388-393.
56. Chambers JT & Schwartz PE. Mobolization of anterior vaginal wall and creation of s neourethral meatus for vulvectomies requiring resection of the distal part of the urethra. Surgery, Gynecology and Obstetrics 1987; 164: 274-275.
57. Hashimoto I, Nakanishi H, Nagae H et al. The gluteal-fold flap for vulvar and buttock reconstruction: Anatomic study and adjustment of flap volume. Plastic and Reconstructive Surgery 2001; 108: 1998-2005.
58. Arkoulakis NS, Angel CL, DuBeshter B & Serletti JM. Reconstruction of an extensive vulvectomy defect using the gluteus maximum fasciocutaneous V-Y advancement flap. Annals of Plastic Surgery 2002; 49: 50-54.
59. Narayansingh GV, Cumming GP, Parkin DP et al. Flap repair: An effective strategy for minimising sexual morbidity associated with surgical management of vulval intra-epithelial neoplasia. Journal of the Royal College of Surgeons of Edinburgh 2000; 45: 81-84.
60. DiSaia PJ, Creasman WT & Rich WM. An alternative approach to early cancer of the vulva. American Journal of Obstetrics and Gynecology 1979; 133: 825-830.
61. Chu J, Tamimi HK & Figge DC. Femoral node metastases with negative superficial inguinal nodes in early vulvar cancer. American Journal of Obstetrics and Gynecology 1981; 140: 337-338.
62. De Cicco C, Sideri M, Bartolomei M et al. Sentinel node biopsy in early vulvar cancer. British Journal of Cancer 2000; 82: 295-299.
63. De Hullu JA, Hollema H, Piers DA et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. Journal of Clinical Oncology 2000; 18: 2811-2816.
64. Zhang SH, Sood AK, Sorosky JI et al. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer 2000; 89: 1520-1525.
65. Nicklin JL, Hacker NF, Heintze SW et al. An anatomical study of inguinal lymph node topography and clinical implications for the surgical management of vulval cancer. International Journal of Gynecological Cancer 1995; 5: 128-133.
66. Paley PJ, Johnson PR, Adcock LL et al. The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. Gynecologic Oncology 1997; 64: 237-241.
67. Fiorica JV, Roberts WS, LaPolla JP et al. Femoral vessel coverage with dura mater after inguinofemoral lymphadenectomy. Gynecologic Oncology 1991; 42: 217-221.
68. Finan MA, Fiorica JV, Roberts WS et al. Artificial dura film for femoral vessel coverage after inguinofemoral lymphadenectomy. Gynecologic Oncology 1994; 55: 333-335.
69. Piver MS, Malfetano JH, Lele SB & Moore RH. Prophylactic anticoagulation as a possible cause of inguinal lymphocyst after radical vulvectomy and inguinal lymphadenectomy. Obstetrics and Gynecology 1983; 62: 17-21.
70. Lawton G Preservation of muscle fascia to decrease lymphoedema after complete axillary and ilioinguinal lymphadenectomy for melanoma. Journal of the American College of Surgeons 2002; 195: 339-351.
71. Bell JG, Jayanthi JS & Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulval carcinoma. Gynecologic Oncology 2000; 77: 314-318.